Abstract
The overactive bladder (OAB) syndrome is increasingly being recognized as a major contributor to the lower urinary tract symptoms in men previously thought to be only due to bladder outlet obstruction from benign prostatic hyperplasia. Medical and surgical treatments that have historically been used to treat women with OAB are being applied to men with great efficacy and a good safety profile. Additionally, treatments such as the β-3 agonist mirabegron, phosphodiesterase-5 inhibitors, sacral and peripheral neuromodulation, and intravesical botulinum toxin injection are promising emerging therapies for the OAB syndrome. This review discusses the evaluation of the male patient with OAB symptoms such as urgency and urge incontinence, and explores the different therapeutic options available for management of men with OAB.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 230-234 |
| Number of pages | 5 |
| Journal | Current Bladder Dysfunction Reports |
| Volume | 7 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 2012 |
Keywords
- Aging
- Benign prostatic hyperplasia (BPH)
- Botulinum toxin A (BOTOX)
- Evaluation
- Lower urinary tract symptoms (LUTS)
- Management
- Men
- Mirabegron
- Neurogenic bladder
- Neuromodulation
- Overactive bladder (OAB)
- PDE5 inhibitor
- Posterior tibial nerve stimulation (PTNS)
- Tadalafil
- Urge incontinence
- Urgency
- Urodynamics
ASJC Scopus subject areas
- Biochemistry
- Molecular Biology